Grant: Project Grant
Queen's University (Kingston, Ontario)
$1,396,125.00
Canadian emergency department-oriented pulmonary embolism testing (the CED-OPET study)
EF 2022-23
Résumé
Pulmonary embolism (blood clots in the lung) can cause death and long-term illness. About half a million Canadians are tested for blood clots in the lung each year. Most Canadians who are tested for blood clots turn out not to have blood clots. Emergency doctors don't follow guidelines for how to test for blood clots and often order scans of the chest. Scans diagnose blood clots, but they also use radiation which can cause cancer, they lead to long delays in the emergency department and they cost money.
Instead of ordering a scan to test for blood clots, emergency doctors can use bedside tests and a blood test called D-dimer to tell them if a scan is needed. Existing bedside tests are not used because they are too complicated and time consuming. Our research team has developed a new, easy-to-use bedside test which is designed for emergency doctors and emergency patients. Our test tells emergency doctors if a scan is needed. To date, our research shows this is a safe test.
We will study our new bedside test with 4,000 emergency department patients who are being tested for blood clots in the lungs. After testing, patients are told to come back to the emergency department if their symptoms don't go away. We will record if study patients are diagnosed with blood clots after having a negative bedside test. Our study will also tell us how many people end up needing a scan with this new bedside test.
If our study proves the new bedside test is safe and effective, it will be used by emergency doctors to test for blood clots in the future. We think our test could save time, reduce costs and tailor blood clot testing for each person.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
478337
Name
de Wit Kerstin
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Clinical
Prcname2
Health Services Evaluation & Interventions Research
Projecttitle
Canadian emergency department-oriented pulmonary embolism testing (the CED-OPET study)
Programtype2
Operating Grants
Orgnameinp2
Queen's University (Kingston, Ontario)
Cihramount2
$1,396,125
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Emergency Department; Pulmonary Embolism; Testing
Abstract
Pulmonary embolism (blood clots in the lung) can cause death and long-term illness. About half a million Canadians are tested for blood clots in the lung each year. Most Canadians who are tested for blood clots turn out not to have blood clots. Emergency doctors don't follow guidelines for how to test for blood clots and often order scans of the chest. Scans diagnose blood clots, but they also use radiation which can cause cancer, they lead to long delays in the emergency department and they cost money.
Instead of ordering a scan to test for blood clots, emergency doctors can use bedside tests and a blood test called D-dimer to tell them if a scan is needed. Existing bedside tests are not used because they are too complicated and time consuming. Our research team has developed a new, easy-to-use bedside test which is designed for emergency doctors and emergency patients. Our test tells emergency doctors if a scan is needed. To date, our research shows this is a safe test.
We will study our new bedside test with 4,000 emergency department patients who are being tested for blood clots in the lungs. After testing, patients are told to come back to the emergency department if their symptoms don't go away. We will record if study patients are diagnosed with blood clots after having a negative bedside test. Our study will also tell us how many people end up needing a scan with this new bedside test.
If our study proves the new bedside test is safe and effective, it will be used by emergency doctors to test for blood clots in the future. We think our test could save time, reduce costs and tailor blood clot testing for each person.
Competitiondate
202303
Approvedterm2
4 yrs 0 mth
Pinamesdelim
de Wit, Kerstin
Approvedterm
4 ans 0 mois
Cihrcontribution2
~ $1,396,125~ $0~